Ticker Sage

Form 4 · LLY

Eli Lilly EVP & Pres. Edgardo Hernandez reports exercising or converting 2,530 shares

Part of a grouped insider digest: see all related filings with totals →

Edgardo Hernandez, Eli Lilly's EVP & Pres., Mfg. Operations, filed a Form 4 on Nov 3, 2026 at 4:14 PM ET reporting transactions on Nov 1, 2026.

The filing reports 2,530 shares in an exercise or conversion of a derivative security (code M); and about 1,123 shares withheld to pay the exercise price or tax (code F).

After these transactions, the filing lists about 47,490 shares held directly.

Effect on holdings

Taken together, the rows reported here raised Edgardo Hernandez's directly held shares by 3.1%, from about 46,083 to about 47,490.

Reporting person

Transactions as reported

DateCodeSecuritySharesPriceAcquired or disposedHeld afterOwnership
2026-11-01MCommon Stock2,530Acquired48,613Direct
2026-11-01FCommon Stock1,123$1,417.54Disposed47,490Direct
2026-11-01MRestricted Stock Unit (derivative)2,530Disposed0Direct

Codes: P purchase, S sale, A grant or award, M/X/C exercise or conversion, F shares withheld for taxes or the exercise price, G gift. Prices are as reported; some are weighted averages of several trades.

Source

Eli Lilly company file → · More Eli Lilly filings

Disclosures

Editor holdings in LLY
The editor holds no position in Eli Lilly (LLY). As of Nov 11, 2026.
Last updated
Nov 3, 2026

A summary of a public filing for general education, the same for every reader. Not a recommendation to buy, sell or hold LLY.